This construct effectively blocked the coinhibitory signaling pathways of PD-1 and CTLA-4, resulting in significant tumor growth suppression and TME remodeling in hCTLA-4/hPD-1 transgenic C57BL/6 mouse models [153]. The gene discussed is PDCD1; the disease is neoplasm.